GS
69
-3
HD
35
-11
EL
55
-3
DRI
63
3
MRO
50
11
K
42
-3
EBAY
43
-2
CF
44
-3
MAC
71
-4
PLD
58
10
COP
47
2
EOG
49
4
UPS
51
-2
IRM
71
-2
FRT
53
3
HPE
44
-2
FSLR
76
3
VLO
45
6
TGNA
66
2
GT
49
-3
GS
69
-3
HD
35
-11
EL
55
-3
DRI
63
3
MRO
50
11
K
42
-3
EBAY
43
-2
CF
44
-3
MAC
71
-4
PLD
58
10
COP
47
2
EOG
49
4
UPS
51
-2
IRM
71
-2
FRT
53
3
HPE
44
-2
FSLR
76
3
VLO
45
6
TGNA
66
2
GT
49
-3
Financhill
Back

Prenetics Global 10K Form

Buy
63

PRE
Prenetics Global

Last Price:
5.86
Seasonality Move:
-42.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRE News And Ratings

See the #1 stock for the next 7 days that we like better than PRE

PRE Financial Statistics

Sales & Book Value

Annual Sales: $21.74M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $16.91
Price / Book: 0.34

Profitability

EPS (TTM): -5.92000
Net Income (TTM): $-62.72M
Gross Margin: $8.83M
Return on Equity: -27.6%
Return on Assets: -22.17%

Prenetics Global Earnings Forecast

Key Prenetics Global Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRE is 40.61%.
  • The Selling, General & Administrative Expenses for PRE have been equal to 228.50% of Gross Profit Margin.
  • The Research & Development expenses have been 53.64% of Revenue.
  • The Interest Expense is -0.19% of Operating Income.
  • The Net Earning history of PRE is -288.48% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 6 years.

Prenetics Global Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: PRE
CUSIP: G6852T
Website: prenetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.37
Quick Ratio: 1.98

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRE Technical Analysis vs Fundamental Analysis

Buy
63
Prenetics Global (PRE) is a Buy

Is Prenetics Global a Buy or a Sell?

  • Prenetics Global stock is rated a Buy
    The current Prenetics Global [PRE] share price is $5.80. The Score for PRE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.